This Revolutionary Treatment Kills Cancer From the Inside Out

We found out that yes, they saw a large mass in my abdomen and knew it was actually large B-cell lymphoma. They didn't really help me. I was encouraged to say that it is a very small percentage of people who get

this

type of

cancer

. I have, but it makes you ask questions like why did I, my wife and I and our church had been praying for me during

this

situation, we prayed again. Well, life could end very soon for me or maybe God would lead us to a place where there could be some

treatment

that would be successful, we had three effective ways to treat

cancer

in the last hundred years and that is surgery, radiotherapy and chemotherapy, despite the better application of these three common modalities, in the United States the number of people who died of cancer is around five.

One hundred and eighty thousand each year, so we desperately need additional ways to treat cancer and we have been developing immunotherapy as a fourth modality to bridge surgery, radiation and chemotherapy. This is Dr. Steve Rosenberg is an oncology surgeon and he has had the most prestigious career a surgeon can have, but if you ask Steve Rosenberg what his life's work is, he wouldn't say it's surgery. For the past 40 years he has been working on a new way to treat cancer. This can make techniques such as surgery obsolete. Immunotherapy does not use a scalpel, a beam of radiation or a medication, external forces on the body, but instead attempts to modify the immune system to fight cancer, the body's own natural defenses that They protect the body well against foreign invaders.

The body recognizes most cancers as foreign, but does not have a strong enough reaction to eliminate those cancers and the goal of immunotherapy is to stimulate immune responses to make those cancers go away. When I started working, there were certainly no effective immunotherapies at all, the first immunotherapy in history. developed was interleukin 2 administration which I started in 1976. Well, we treated 66 patients over many years trying to find the best ways to stimulate the body's immune system. None of those

treatment

s work. 66 consecutive patients died until the 67th patient was a woman. Her name is Linda, I can use her name because she has appeared in newspapers all over the country.

Linda is now alive 30 years later, she had widespread melanoma and it was all gone and she was just the first of many patients who have now been shown to respond to immunotherapy. Interleukin 2 alone was effective. for a small fraction of patients, but it turned out that dr. Rosenberg's idea could work; he and his team have spent the last 30 years trying to improve the treatment. They have recently made a breakthrough thanks to advances in genetic engineering. Basically, they can take your own immune cells and reprogram them to attack cancer. We can isolate the lymphocytes from the blood that are the immune warriors of the body and then introduce new genes into the lymphocytes to give them a property that recognizes and destroys cancer, then we go ahead and expand them into large quantities and administer them to patients.

Rosenberg is now testing this approach in patients who do not respond to any other form of treatment, so mr. Oaks came to us after having gone through multiple chemotherapy regimens that had not helped him and he came to us with a large mass the size of a grapefruit in his abdomen and you can see it on this cat scan right here. Finally they said that the chemotherapy was not finished. If it doesn't work for you, you're not responding well, so there's nothing else we can do for you; However, there are some new experimental programs going on at the National Institutes of Health in Bethesda, Maryland, and we are going to try to help you.

On those, they took some of my blood and did some work in our lab for about five days, put it back in and let it work attacking the cancer. The treatment is quite simple and is ready in approximately a month. It's good to see you walking. Hey, I mean, when we come back for our first checkup, it's really the first indication of how well the treatment worked. They said we didn't see active cancer and my wife and I just held hands and said thank God and thank you dr. Rosenberg, that's a big relief, hello sir, nice to see you again, a little greasy here, oh yes, very clean mojito, that's good, that big mass that was in your belly we see that it continues to shrink.

Now it has shrunk to that size, but it is dead. we can say that the tumor has to respond completely, so we are excited because you are excited and we have also learned a lot from you that I think will help a lot of other people as well. It's a very new type of approach, as you know, we genetically manipulate the immune system, but in this situation it seems to be working well. Any questions you have for me, well, not right now, if you don't mind, I'll forget that I had cancer for about three more months.

Later I will return another trip that is what we like it is so pleasant to live together every day keep in touch well thank you okay dr. Rosenberg has had great success with this latest version of the treatment of him. It has caused regression in more than 70% of lymphoma patients in its clinical trials. It is an exciting time for the field of immunotherapy that dr. Rosenberg was a pioneer and it has taken him more than 40 years of determined search to get to this point, but he is the first to point out that any talk about a cure is still a long way off, the problem is that it does not always work and, above all, when treats solid tumors, it works much less well than in patients with these blood cell tumors, lymphomas, so we are working day and night to apply these types of approaches to patients with common solid cancers, such as colon cancers. and the pancreas, ovary and prostate, until we can apply effective treatments to all the innocent people who develop cancer, there is much work to be done.